Period:
Draw Mode:
| Volume | 39,217 |
|
|||||
| News | - | ||||||
| Day High | 0.729 | Low High |
|||||
| Day Low | 0.6794 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Harpoon Therapeutics Inc | HARP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04155 | 6.33% | 0.697953 | 09:51:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7138 | 0.6794 | 0.729 | 0.6564 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 91 | 39,217 | $ 0.7118112 | $ 27,915 | - | 0.544 - 3.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:59:28 | 1 | $ 0.70 | USD |
Harpoon Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 26.24M | 37.60M | 24.28M | $ 8.58M | $ -113.30k | -0.31 | -231.61 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 582.60k | - |
Harpoon Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HARP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.77 | 0.79 | 0.60 | 0.7047248 | 123,792 | -0.07205 | -9.36% |
| 1 Month | 0.55 | 0.8572 | 0.545 | 0.7318695 | 163,769 | 0.14795 | 26.9% |
| 3 Months | 0.72 | 0.8572 | 0.544 | 0.6936835 | 217,691 | -0.02205 | -3.06% |
| 6 Months | 0.67 | 3.35 | 0.544 | 1.20 | 1,250,260 | 0.02795 | 4.17% |
| 1 Year | 2.12 | 3.35 | 0.544 | 1.25 | 708,653 | -1.42 | -67.08% |
| 3 Years | 21.60 | 25.235 | 0.544 | 6.14 | 439,469 | -20.90 | -96.77% |
| 5 Years | 13.88 | 25.235 | 0.544 | 6.84 | 330,408 | -13.18 | -94.97% |
Harpoon Therapeutics Description
| Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others. |